Who is sponsoring NCT05831046?

NCT05831046 is sponsored by Duke University.

What drugs are being tested in NCT05831046?

Interventions in NCT05831046: ED management software.

What condition does NCT05831046 study?

NCT05831046 studies Emergency Department Waiting Room Congestion.

Is NCT05831046 still recruiting?

NCT05831046 is currently completed. Last updated 9 July 2025.

Last reviewed 2025-07-09 · How we verify

NCT05831046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Emergency Department Re-evaluation Software Pilot Study

Completed NA Last updated 9 July 2025

What this trial tests

NA trial testing ED management software in Emergency Department Waiting Room Congestion in 20 participants. Completed in 10 June 2025.

Timeline

3 October 2023

Primary endpoint
10 June 2025

10 June 2025

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	20
Start date	3 October 2023
Primary completion	10 June 2025
Estimated completion	10 June 2025
Sites	1 location across United States

Drugs / interventions tested

ED management software

Conditions studied

Emergency Department Waiting Room Congestion — all drugs for Emergency Department Waiting Room Congestion →

Sponsor

Duke University

Who can join

18 and older, any sex, with Emergency Department Waiting Room Congestion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a research study to determine a method in improving emergency department waiting room care by using new software program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05831046 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 9 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05831046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing